Plasma cell formation, secretion, and persistence: The short and the long of it

Critical Reviews in Immunology

Volumn 34, Issue 6, 2014, Pages 481-500

  Bayles, Ian ^a   Milcarek, Christine ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody secreting cells; B cell differentiation; Immunoglobulin; Plasma cells

Indexed keywords

B CELL ACTIVATING FACTOR; BLOOD GROUP B ANTIBODY; CCAAT ENHANCER BINDING PROTEIN; COMPLEMENT RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION ELONGATION FACTOR; TRANSCRIPTION FACTOR ELL2; UNCLASSIFIED DRUG; ANTIBODY; B CELL MATURATION ANTIGEN; ELL2 PROTEIN, HUMAN; IMMUNOGLOBULIN HEAVY CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR; TNFRSF17 PROTEIN, HUMAN;

ANTIBODY PRODUCTION; ANTIBODY SECRETING CELL; ARCHITECTURE; ARTICLE; AUTOPHAGY; B LYMPHOCYTE; BONE MARROW; BONE MARROW STROMA CELL; CELL SURVIVAL; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HEAVY CHAIN; HUMAN; HYPOXIA; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; LONG TERM SURVIVAL; LONGEVITY; MULTIPLE MYELOMA; NONHUMAN; OXYGEN TENSION; PLASMA CELL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; UPREGULATION; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; SECRETION (PROCESS);

ANTIBODIES; AUTOPHAGY; B-CELL MATURATION ANTIGEN; CELL DIFFERENTIATION; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; PLASMA CELLS; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, COMPLEMENT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ELONGATION FACTORS; UNFOLDED PROTEIN RESPONSE;

EID: 84918815676     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevImmunol.2014012168     Document Type: Article

References (144)

1. Bosma M, Weiler E. The clonal nature of antibody formation. I. clones of antibody-forming cells of poly- D-alanine specificity. J Immunol. 1970;104:203–14
2. Lefkovits I. Induction of antibody-forming cell clones in microcultures. Eur J Immunol. 1972;2:360–6
3. Manz RA, Radbruch A. Plasma cells for a lifetime? Eur J Immunol. 2002;32(4):923–7
4. Chen-Kiang S. Cell-cycle control of plasma cell differentiation and tumorigenesis. Immunol Rev. 2003;194:39–47
5. Bouchard C, Fridman WH, Sautes C. Effect of TGF-beta1 on cell cycle regulatory proteins in LPSstimulated normal mouse B lymphocytes. J Immunol. 1997;159:4155–64
6. Lamson GL, Koshland ME. Changes in J chain and mu chain mRNA expression as a function of B cell differentiation. J Exp Med. 1984;160:877–92
7. Amigorena S, Bonnerot C, Choquet D, Fridman WH, Teillaud JL. Fc gamma RII expression in resting and activated B lymphocytes. Eur J Immunol. 1989;19(8):1379–85
8. van Anken E, Romijn EP, Maggioni C, Mezghrani A, Sitia R, Braakman I, Heck AJ. Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion. Immunity. 2003;18(2):243–53
9. Noelle R, Ledbetter A, Aruffo A. CD40 and its ligand, an essential ligand receptor pair for thymus-dependent B-cell activation. Immunol Today. 1992;13:431
10. Malisan F, Briere F, Bridon J-M, Harindranath N, Mills C, Max E, Banchereau J, Martinez-Valdez H. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J Exp Med. 1996;183:937–47
11. Jacquot S, Kobata T, Iwata S, Morimoto C, Schlossman S. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses. J Immunol. 1997;159:2652–7
12. Nagumo H, Agematsu K, Shinozaki K, Hokibara S, Ito S, Takamoto M, Nikaido T, Yasui K, Uehara Y, Yachie A, Komiyama A. CD27/CD 70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J Immunol. 1998;161(12): 6496–502
13. Stuber E, Neurath M, Calderhead D, Fell H, Strober W. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family induces proliferation and differentiation in murine splenic cells. Immunity. 1995;2:507–21
14. Matsui K, Nakanishi K, Cohen DI, Hada T, Furuyama J, Hamaoka T, Higashino K. B-cell response pathways regulated by IL-5 and IL-2. Secretory muH chainmRNA and J chain mRNA expression are separately controlled events. J Immunol. 1989;142:2918–23
15. Rodríguez C, Roldán E, Navas G, Brieva JA. Essential role of tumor necrosis factor-α in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high-rate immunoglobulin secretion. Eur J Immunol. 1993;23(5):1160–4
16. Kikutani H, Taga T, Akira S, Kishi H, Miki Y, Saiki O, Yamamura Y, Kishimoto T. Effect of B cell differentiation factor (BCDF) on biosynthesis and secretion of Ig molecules in human B cell lines. J Immunol. 1985;134:990–5
17. Moens L, Tangye SG. Cytokine-mediated regulation of plasma cell generation: IL-21 takes center stage. Frontiers in Immunology. 2014 Feb 18;5
18. Yuan D. Molecular basis for the inhibition of LPS induced differentiation by anti-immunoglobulin. J Mol Cell Immunol. 1987;3(3):133–44
19. Phillips C, Schimpl A, Dietrich-Goetz W, Clements J, Virtanen A. Inducible nuclear factors binding the IgM heavy chain pre-mRNA secretory poly(A) site. Eur J Immunol. 1996;26(12):3144–52
20. Chen U. Analysis of cell proliferation and mu-RNA processing during activation of mouse B-cells by anti-mu and T lymphocytes. Mol Immunol. 1990;27(12):1249–57
21. Chen U, Scheuermann R, Wirth T, Gerster T, Roeder R, Harshman K, Berger C. Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells. Nucleic Acids Res. 1991;19:5981–9
22. Nutt SL, Taubenheim N, Hasbold J, Corcoran LM, Hodgkin PD. The genetic network controlling plasma cell differentiation. Semin Immunol. 2011;23(5):341–9
23. Fairfax KA, Kallies A, Nutt SL, Tarlinton DM. Plasma cell development: from B-cell subsets to long-term survival niches. Semin Immunol. 2008;20(1):49–58
24. Carotta S, Willis SN, Hasbold J, Inouye M, Pang SH, Emslie D, Light A, Chopin M, Shi W, Wang H, Morse HC 3rd, Tarlinton DM, Corcoran LM, Hodgkin PD, Nutt SL. The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation. J Exp Med. 2014 Oct 20;211(11):2169–81
25. Grötsch B, Brachs S, Lang C, Luther J, Derer A, Schlötzer-Schrehardt U, Bozec A, Fillatreau S, Berberich I, Hobeika E, Reth M, Wagner EF, Schett G, Mielenz D, David JP. The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells. J Exp Med. 2014 Oct 20;211(11):2199–212
26. Park KS, Bayles I, Szlachta-McGinn A, Paul J, Boiko J, Santos P, Liu J, Wang Z, Borghesi L, Milcarek C. Transcription enlongation factor ELL2 drives immunoglobulin secretory specific mRNA production and the unfolded protein response. J Immunol. 2014;193:4663–74
27. Benhamron S, Pattanayak SP, Berger M, Tirosh B. mTOR activation promotes plasma cell differentiation and bypasses XBP-1 for immunoglobulin secretion. Mol Cell Biol. 2014 Oct 20
28. Lu D, Nakagawa R, Lazzaro S, Staudacher P, Abreu- Goodger C, Henley T, Boiani S, Leyland R, Galloway A, Andrews S, Butcher G, Nutt SL, Turner M, Vigorito E. The miR-155–PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation. The Journal of Experimental Medicine. 2014 Oct 20;211(11):2183–98
29. Mittrucker HW. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 1997;275:540–3
30. Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T, Ludwig T, Rajewsky K, Dalla-Favera R. Transcription factor IRF4 controls plasma cell differentiation and classswitch recombination. Nat Immunol. 2006;7(7):773–82
31. Shaffer AL, Emre NCT, Lamy L, Ngo VN, Wright G, Xiao W, Powell J, Dave S, Yu X, Zhao H, Zeng Y, Chen B, Epstein J, Staudt LM. IRF4 addiction in multiple myeloma. Nature. 2008;454:226–31
32. Willis SN, Good-Jacobson KL, Curtis J, Light A, Tellier J, Shi W, Smyth GK, Tarlinton DM, Belz GT, corcoran LM, Kallies A, Nutt SL. Transcription factor IRF4 regulates germinal center cell formation through a B cell-intrinsic mechanism. J Immunol. 2014 Apr 1;192(7):3200–6
33. Ochiai K, Maienschein-Cline M, Simonetti G, Chen J, Rosenthal R, Brink R, Chong AS, Klein U, Dinner AR, Singh H, Sciammas R. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity. 2013;38(5):918–29
34. Sciammas R. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity. 2006;25:225–36
35. Pongubala JM, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3’ enhancer activity. Mol Cell Biol. 1992 Jan 1;12(1):368–78
36. Su GH, Ip HS, Cobb BS, Lu MM, Chen HM, Simon MC. The Ets protein Spi-B is expressed exclusively in B cells and T cells during development. J Exp Med. 1996 Jul 1;184(1):203–14
37. Lee SC, Bottaro A, Insel RA. Activation of terminal B cell differentiation by inhibition of histone deacetylation. Mol Immunol. 2003;39(15):923–32
38. John SA, Clements JL, Russell LM, Garrett-Sinha LA. Ets-1 regulates plasma cell differentiation by interfering with the activity of the transcription factor blimp-1. J Biol Chem. 2008 Jan 11;283(2):951-62
39. Fernández D, Ortiz M, Rodríguez L, García A, Martinez D, Moreno de Alborán I. The proto-oncogene c-myc regulates antibody secretion and Ig class switch recombination. J Immunol. 2013 Jun 15;190(12): 6135–44
40. Kallies A, Hasbold J, Fairfax K, Pridans C, Emslie D, McKenzie BS, Lew AM, Corcoran LM, Hodgkin PD, Tarlinton DM, Nitt SL. Initiation of plasma-cell differentiation is independent of the transcription factor blimp-1. Immunity. 2007;26:555–66
41. SShaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, Zhao H, Yu X, Yang L, Tan BK, Rosenwald A, Hurt EM, Petroulakis E, Sonenberg N, Yewdell JW, Calame K, Glimcher LH, Staudt LM. XBP1, downstream of blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity. 2004;21:81–93
42. Ma Y, Shimizu Y, Mann MJ, Jin Y, Hendershot LM. Plasma cell differentiation initiates a limited ER stress response by specifically suppressing the PERK-dependent branch of the unfolded protein response. Cell Stress Chaperones. 2010;15(3):281–93
43. Takayanagi S, Fukuda R, Takeuchi Y, Tsukada S, Yoshida K. Gene regulatory network of unfolded protein response genes in endoplasmic reticulum stress. Cell Stress Chaperones. 2013;18(1):11–23
44. Gass JN, Gifford NM, Brewer JW. Activation of an unfolded protein response during differentiation of antibody-secreting B cells. J Biol Chem. 2002 Dec 13;277(50):49047–54
45. Gass JN, Jiang H-Y, Wek RC, Brewer JW. The unfolded protein response of B-lymphocytes: PERK-independent development of antibody-secreting cells. Mol Immunol. 2008;45(4):1035–43
46. Aragon IV, Barrington RA, Jackowski S, Mori K, Brewer JW. The specialized unfolded protein response of B lymphocytes: ATF6α-independent development of antibody-secreting B cells. Mol Immunol. 2012;51(3–4):347–55
47. Reimold A, Iwakoshi N, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F, Glimcher LH. Plasma cell differentiation requires the transcription factor XBP-1. Nature. 2001;412:300–7
48. Tirosh B, Iwakoshi NN, Glimcher LH, Ploegh HL. XBP-1 specifically promotes IgM synthesis and secretion, but is dispensable for degradation of glycoproteins in primary B cells. J Exp Med. 2005 Aug 15;202(4):505–16
49. Taubenheim N, Tarlinton DM, Crawford S, Corcoran LM, Hodgkin PD, Nutt SL. High rate of antibody secretion is not integral to plasma cell differentiation as revealed by XBP-1 deficiency. J Immunol. 2012 Oct 1;189(7):3328–38
50. Benhamron S, Hadar R, Iwawaky T, So J-S, Lee A-H, Tirosh B. Regulated IRE-1 dependent decay participates in curtailing immunoglobulin secretion from plasma cells. Eur J Immunol. 2014;44:867–76
51. Hollien J, Lin JH, Li H, Stevens N, Walter P, Weissman JS. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell Biol. 2009;186(3):323–31
52. Tirasophon W, Lee K, Callaghan B, Welihinda A, Kaufman RJ. The endoribonuclease activity of mammalian IRE1 autoregulates its mRNA and is required for the unfolded protein response. Genes Dev. 2000 Nov 1;14(21):2725–36
53. Lee K, Tirasophon W, Shen X, Michalak M, Prywes R, Okada T, Yoshida H, Mori K, Kaufman RJ. IRE1- mediated unconventional mRNA splicing and S2Pmediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 2002 Feb 15;16(4):452–66
54. Iwawaki T, Akai R, Kohno K. IRE1α disruption causes histological abnormality of exocrine tissues, increase of blood glucose level, and decrease of serum immunoglobulin level. PLOS One. 2010;5(9):e13052
55. Peterson ML. Mechanisms controlling production of membrane and secreted immunoglobulin during B cell development. Immunol Res. 2007;37(1):33–48
56. Borghesi L, Milcarek C. From B cell to plasma cell: regulation of V(D)J recombination and antibody secretion. Immunol Res. 2006;36(1-3):27–32
57. Martincic K, Alkan SA, Cheatle A, Borghesi L, Milcarek C. Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing. Nat Immunol. 2009;10(10):1102–9
58. Milcarek C, Albring M, Langer C, Park KS. The eleven-nineteen lysine-rich leukemia gene (ELL2) influences the histone H3 modifications accompanying the shift to secretory Immunoglobulin heavy chain mRNA production. J Biol Chem. 2011 Aug 9;286: 33795–803
59. Shell SA, Martincic K, Tran J, Milcarek C. Increased phosphorylation of the carboxyl terminal domain of RNA polymerase II and loading of polyadenylation and co-transcriptional factors contribute to regulation of the Ig heavy chain mRNA in plasma cells. J Immunol. 2007;179:7663–73
60. Peterson ML, Perry RP. The regulated production of mu-m and mu-s mRNA is dependent on the relative efficiencies of mu-s poly(A) site usage and the Cmu4 to M1 splice. Mol Cell Biol. 1989;9:726-38
61. Bruce SR, Dingle RWC, Peterson ML. B-cell and plasma-cell splicing differences: A potential role in regulated immunoglobulin RNA processing. RNA. 2003 Oct 1;9(10):1264–73
62. Veraldi KL, Arhin GK, Martincic K, Chung-Ganster L, Wilusz J, Milcarek C. hnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B-cells. Mol Cell Biol. 2001;21:1228–38
63. Milcarek C, Martincic K, Chung-Ganster L-H, Lutz CS. The snRNP-associated U1A levels change following IL-6 stimulation of human B-cells. Mol Immunol. 2003;39:809–14
64. Alkan SA, Martincic K, Milcarek C. The hnRNPs F and H2 bind to similar sequences to influence gene expression. Biochem J. 2006;393:361–71
65. Ma J, Gunderson SI, Phillips C. Non-snRNP U1A levels decrease during mammalian B-cell differentiation and release the IgM secretory poly(A) site from repression. RNA. 2006 Jan 1;12(1):122–32
66. Tian B, Hu J, Zhang H, Lutz CS. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucl Acids Res. 2005 Jan 12;33(1):201–12
67. Edwalds-Gilbert G, Veraldi K, Milcarek C. Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res. 1997;25: 2547–61
68. Lutz CS, Moreira A. Alternative mRNA polyadenylation in eukaryotes: an effective regulator of gene expression. Wires RNA. 2011;2:23–31
69. Tunyaplin C, Shapiro MA, Calame KL. Characterization of the B lymphocyte-induced maturation protein-1 (Blimp-1) gene, mRNA isoforms and basal promoter. Nucleic Acids Res. 2000 Dec 15;28(24):4846–55
70. Rigo F, Martinson HG. Functional coupling of last-intron splicing and 3’-end processing to transcription in vitro: the poly(A) signal couples to splicing before committing to cleavage. Mol Cell Biol. 2008 Jan 15;28(2):849–62
71. Tian B, Pan Z, Lee JY. Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing. Genome Res. 2007 Feb 1;17(2):156–65
72. Ji Z, Tian B. Reprogramming of 3’UTR untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types. PLoS ONE. 2009 Dec 23;4(12):e8419
73. Ji Z, Lee JY, Pan Z, Jiang B, Tian B. Progressive lengthening of 3’ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc Natl Acad Sci U S A. 2009 April 28;106(17):7028–33
74. Takagaki Y, Manley J. Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. Mol Cell. 1998;2:761–71
75. Martincic K, Campbell R, Edwalds-Gilbert G, Souan L, Lotze M, Milcarek C. Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the Go to S phase transition. Proc Natl Acad Sci U S A. 1998;95(19):11095–100
76. Mann MC, Strobel S, Fleckenstein B, Kress AK. The transcription elongation factor ELL2 is specifically upregulated in HTLV-1-infected T-cells and is dependent on the viral oncoprotein tax. Virology. 2014;464–465(0):98–110
77. Benson MJ, Äijö T, Chang X, Gagnon J, Pape UJ, Anantharaman V, Aravind L, Pursiheimo JP, Oberdoerffer S, Liu XS, Lahesmaa R, Lähdesmäki H, Rao A. Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells. Proc Nat Acad Sci U S A. 2012 Oct 2;109(40):16252–7
78. O’Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, Lin LL, Mantchev GT, Bram RJ, Noelle RJ. BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells. J Exp Med. 2004 Jan 5;199(1):91–8
79. Xu S, Lam KP. B-cell maturation protein, which binds the tumor necrosis factor famliy members BAFF and APRIL, is dispensible for humoral immune responses. Mol Cell Biol. 2001;21:4067–74
80. Nixon JC, Rajaiya J, Webb CF. Mutations in the DNAbinding domain of the transcription factor, bright, act as dominant negative proteins and interfere with immunoglobulin transactivation. J Biol Chem. 2004 Sep 27;279:52465–72
81. Oldham AL, Miner CA, Wang HC, Webb CF. The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production. Mol Immunol. 2011;49:367–79
82. Webb CF, Bryant J, Popowski M, Allred L, Kim D, Harriss J, Schmidt C, Miner CA, Rose K, Cheng HL, Griffin C, Tucker PW The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development. Mol Cell Biol. 2011 Mar 1;31(5):1041–53
83. Chiu YK, Lin IY, Su ST, Wang KH, Yang SY, Tsai DY, Hsieh YT, Lin KI. Transcription factor ABF-1 suppresses plasma cell differentiation but facilitates memory B cell formation. J Immunol. 2014 Jul 28
84. Massari ME, Rivera RR, Voland JR, Quong MW, Breit TM, van Dongen JJ, de Smit O, Murre C. Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol Cell Biol. 1998 June 1;18(6):3130–9
85. Grandori C, Eisenman RN. Myc target genes. Trends Biochem Sci. 1997;22(5):177–81
86. Chevrier S, Emslie D, Shi W, Kratina T, Wellard C, Karnowski A, Erikci E, Smyth GK, Chowdhury K, Tarlinton D, Corcoran LM. The BTB-ZF transcription factor Zbtb20 is driven by Irf4 to promote plasma cell differentiation and longevity. J Exp Med. 2014 Apr 7;211:827–40
87. Wang Y, Bhattacharya D. Adjuvant-specific regulation of long-term antibody responses by ZBTB20. J Exp Med. 2014 May 5;211(5):841–56
88. Liu X, Zhang P, Bao Y, Han Y, Wang Y, Zhang Q, Zhan Z, Meng J, Li Y, Li N, Zhang WJ, Cao X. Zinc finger protein ZBTB20 promotes toll-like receptortriggered innate immune responses by repressing IκBα gene transcription. Proc Nat Acad Sci U S A. 2013 June 17;110:11097–102
89. Takami Y, Kikuchi H, Nakayama T. Chicken histone deacetylase-2 controls the amount of the IgM H-chain at the steps of both transcription of its gene and alternative processing of its pre-mRNA in the DT40 cell line. J Biol Chem. 1999;34:23977–90
90. Nakayama M, Suzuki H, Yamamoto-Nagamatsu N, Barman HK, Kikuchi H, Takami Y, Toyonaga K, Yamashita K, Nakayama T. HDAC2 controls IgM H- and L-chain gene expressions via EBF1, Pax5, Ikaros, Aiolos and E2A gene expressions. Genes Cells. 2007;12(3):359–73
91. Kikuchi H, Nakayama M, Kuribayashi F, Imajoh-Ohmi S, Nishitoh H, Takami Y, Nakayama T. GCN5 is involved in regulation of immunoglobulin heavy chain gene expression in immature B cells. Gene. 2014;544(1):19–24
92. Agudelo M, Newton C, Widen R, Sherwood T, Nong L, Friedman H, Klein TW. Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes. J Neuroimmune Pharm. 2008;3(1):35–42
93. Eisenstein TK, Meissler JJ, Wilson Q, Gaughan JP, Adler MW. Anandamide and Δ9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors. J Neuroimmunol. 2007;189(1–2):17–22
94. Feng R, Milcarek CA, Xie X-Q. Antagonism of cannabinoid receptor 2 pathway suppresses IL-6 induced immunoglobulin IgM secretion. BMC Pharm Tox. 2014;15:1–8
95. Kumazaki K, Tirosh B, Maehr R, Boes M, Honjo T, Ploegh HL. AID−/−μs−/− mice are agammaglobulinemic and fail to maintain B220−CD138+ plasma cells. J Immunol. 2007 Feb 15;178(4):2192–203
96. Zhang S, Pruitt M, Tran D, Du Bois W, Zhang K, Patel R, Hoover S, Simpson RM, Simmons J, Gary J, Snapper CM, Casellas R, Mock BA. B cell-specific deficiencies in mTOR limit humoral immune responses. J Immunol. 2013 Aug 15;191(4):1692–703
97. Zhou P, Ma X, Iyer L, Chaulagain C, Comenzo RL. One siRNA pool targeting the lambda constant region stops lambda light-chain production and causes terminal endoplasmaic reticulum stress. Blood. 2014;123:3440–51
98. Minges Wols HA, Ippolito JA, Yu Z, Palmer JL, White FA, Le PT, Witte PL. The effects of microenvironment and internal programming on plasma cell survival. Int Immunol. 2007 Jul 1;19(7):837–46
99. Winkelmann R, Sandrock L, Porstner M, Roth E, Mathews M, Hobeika E, Reth M, Kahn ML, Schuh W, Jäck HM. B cell homeostasis and plasma cell homing controlled by Krüppel-like factor 2. ProcNat Acad Sci, USA. 2011 Jan 11;108(2):710–5
100. Mackay F, Schneider P, Rennert P, Browning J. BAFF AND APRIL: A Tutorial on B Cell Survival. Ann Rev Imm. 2003;21(1):231–64
101. Lopes-Carvalho T, Foote J, Kearney JF. Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol. 2005;17(3):244–50
102. Lopes-Carvalho T, Kearney JF. Development and selection of marginal zone B cells. Immunol Rev. 2004;197(1):192–205
103. Auner HW, Beham-Schmid C, Dillon N, Sabbattini P. The life span of short-lived plasma cells is partly determined by a block on activation of apoptotic caspases acting in combination with endoplasmic reticulum stress. Blood. 2010;116:3445–55
104. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol. 2009;9(11):767–77
105. McHeyzer-Williams LJ, McHeyzer-Williams MG. n. Annu Rev Immunol. 2005;25:487–513
106. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KGC, Dörner T, Hiepe Fl. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol. 2006;6(10):741–50
107. Good-Jacobson KL, Shlomchik MJ. Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: the influence of germinal center interactions and dynamics. J Immunol. 2010 Sep 15;185(6):3117–25
108. Conter LJ, Song E, Shlomchik MJ, Tomayko MM. CD73 Expression is dynamically regulated in the germinal center and bone marrow plasma cells are diminished in its absence. PLOS One. 2014
109. Zuccarino-Catania GV, Sadanand S, Weisel FJ, Tomayko MM, Meng H, Kleinstein SH, Good-Jacobson KL, Shlomchik MJ. CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. Nat Immunol. 2014;15(7):631–7
110. Zabel F, Mohanan D, Bessa J, Link A, Fettelschoss A, Saudan P, Kündig TM Bachmann MF. Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies. J Immunol. 2014 May 12;192:5499–508
111. Njau MN, Kim JH, Chappell CP, Ravindran R, Thomas L, Pulendran B, Jacob J. CD28–B7 Interaction modulates short- and long-lived plasma cell function. J Immunol. 2012 Sep 15;189(6):2758–67
112. Hoyer BF, Moser K, Hauser AJ, Peddinghaus A, Voigt C, Eilat D, Radbruch A, Hiepe F, Manz RA. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med. 2004;199:1577–84
113. Liu Z, Zou Y-R, Davidson A. Plasma cells in systemic lupus erythematosus: the long and short of it all. Eur J Immunol. 2011;41(3):588–91
114. Zhang X, Paun A, Claudio E, Wang H, Siebenlist U. The tumor promoter and NF-κB modulator Bcl- 3 regulates splenic B cell development. J Immunol. 2013;191:5984–92
115. Hagman J, Ramírez J, Lukin K. B Lymphocyte lineage specification, commitment and epigenetic control of transcription by early B cell factor 1. In: Murre C, editor. Epigenetic regulation of lymphocyte development. Berlin: Springer; 2012. p. 17–38
116. Vilagos B, Hoffmann M, Souabni A, Sun Q, Werner B, Medvedovic J, Bilic I, Minnich M, Axelsson E, Jaritz M, Busslinger M. Essential role of EBF1 in the generation and function of distinct mature B cell types. J Exp Med. 2012 Apr 9;209(4):775–92
117. Györy I, Boller S, Nechanitzky R, Mandel E, Pott S, Liu E, Grosschedl R. Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. Genes Dev. 2012 Apr 1;26(7):668–82
118. Jiang Y, Soong TD, Wang L, Melnick AM, Elemento O. Genome-wide detection of genes targeted by non- Ig somatic hypermutation in lymphoma. PLoS ONE. 2012;7(7):e40332
119. Bertolotti M, Sitia R, Rubartelli A. On the redox control of B lymphocyte differentiation and function. Antiox Redox Signal. 2012;16:1139–49
120. Nakajima S, Kitamura M. Bidirectional regulation of NF- κB by reactive oxygen species: a role of unfolded protein response. Free Radical Biol Med. 2013;65(0):162–74
121. Saito M, Novak U, Piovan E, Basso K, Sumazin P, Schneider C, Crespo M, Shen Q, Bhagat G, Califamo A, Chadburn A, Pasqualucci L, Dalla-Favera R. BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11294–9
122. Novo E, Parola M. Redox mechanisms in hepatic chronic would healing and fibrogenesis. Fibrogenesis Tissue Repair. 2008;1:5–63
123. Lee RL, Westendorf J, Gold MR. Differential role of reactive oxygen species in the activation of mitogenactivated protein kinases and Akt by key receptors on B-lymphocytes: CD40, the B cell antigen receptor, and CXCR4. J Cell Commun Signal. 2007;1:33–43
124. Pengo N, Scolari M, Oliva L, Milan E, Mainoldi F, Raimondi A, Fagioli C, Merlini A, Mariani E, Pasqualetto E, Orfanelli U, Ponzoni M, Sitia R, Casola S, Cenci S. Plasma cells require autophagy for sustainable immunoglobulin production. Nat Immunol. 2013;14:298–305
125. Hansen WR, Barcistress N, Taylor L, Curthoys NP. The 3’-nontranslated region of rat renal glutaminase mRNA contains a pH-responsive stability element. Am J Physiol Renal Physiol. 1996;40(1):F126–F31
126. Hombach J, Lottspeich F, Reth M. Identification of the genes encoding the IgM-α and Ig-β components of the IgM antigen receptor complex by amino-terminal sequencing. Eur J Immunol. 1990;20(12):2795–9
127. Price PW, McKinney EC, Wang Y, Sasser LE, Kandasamy MK, Matsuuchi L, Milcarek C, Deal RB, Culver DG, Meagher RB. Engineered cell surface expression of membrane immunoglobulin as a means to identify monoclonal antibody-secreting hybridomas. J Immunol Methods. 2009;343:28–41
128. Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol. 2009;9(7):491–502
129. Peperzak V, Vikstrom I, Walker J, Glaser SP, LePage M, Coquery CM, Erickson LD, Fairfax K, Mackay F, Strasser A, Nutt SL, Tarlinton DM. Mcl-1 is essential for the survival of plasma cells. Nat Immunol. 2013;14(3):290–7
130. Pyo JO, Yoo SM, Ahn HH, Nah J, Hong SH, Kam TI, Jung S, Jung YK. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat Commun. 2013;4:2300
131. Deegan S, Saveljeva S, Gorman A, Samali A. Stressinduced self-cannibalism: on the regulation of autophagy by endoplasmic reticulum stress. Cell Mol Life Sci. 2013;70(14):2425–41
132. Masciarelli S, Fra AM, Pengo N, Bertolotti M, Cenci S, Fagioli C, Ron D, Hendershot LM, Sitia R. CHOPindependent apoptosis and pathway-selective induction of the UPR in developing plasma cells. Mol Immunol. 2010;47(6):1356–65
133. Gaudette BT, Iwakoshi NN, Boise LH. Bcl-xL protein protects from C/EBP homologous protein (CHOP)- dependent apoptosis during plasma cell differentiation. J Biol Chem. 2014 Aug 22;289(34):23629–40
134. Wong WJ, Qiu B, Nakazawa MS, Qing G, Simon MC. MYC Degradation under low O2 tension promotes survival by evading hypoxia-induced cell death. Mol Cell Biol. 2013 Sep 1;33(17):3494–504
135. Levine B. Cell biology: autophagy and cancer. Nature. 2007;446(7137):745–7
136. Marin-Hernandez A, Gallardo-Perez JC, Ralph SJ, Rodriguez-Enriquez S, Moreno-Sanchez R. Hif-1alpha modulates eneregy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem. 2009;9:1084–101
137. Keren DF. Laboratory evaluation for monoclonal gammopthies: MGUS to myeloma. Warde Med Lab. 2010;21(2).
138. Chesi M, Bergsagel PL. Many multiple myelomas: making more of the molecular mayhem. ASH Educ Program Book. 2011 Dec 10;2011(1):344–53
139. Gu ZJ, Costes V, Lu ZY, Zhang XG, Pitard V, Moreau JF, Bataille R, Wijdenes J, Rossi JF, Klein B. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood. 1996;88(10):3972–86
140. van Laar JM, Melchers M, Tang YK, van der Zouwen B, Mohammadi R, Fischer R, Margolis L, Fitzgerald W, Grivel JC, Breedveld FC, Lipsky PE, Grammer AC. Sustained secretion of immunoglobulin by long-lived human tonsil plasma cells. Am J Path. 2007;171:917–27
141. Boylan KLM, Gosse MA, Staggs SE, Janz S, Grindle S, Kansas GS, Van Ness BG. A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma. Cancer Res. 2007 May 1, 2007;67(9):4069–78
142. Hu J, Van Valckenborgh E, Menu E, De Bruyne E, Vanderkerken K. Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models. Dis Models Mech. 2012 Nov 1, 2012;5(6):763–71
143. Galbraith MD, Allen MA, Bensard CL, Wang XD, Schwinn MK, Qin B, Long HW, Daniels DL, Hahn WC, Dowell RD, Espinosa JM. HIF1A employs CDK8- mediator to stimulate RNAPII elongation in response to hypoxia. Cell. 2013;153(6):1327–39
144. Storti P, Bolzoni M, Donofrio G, Airoldi I, Guasco D, Toscani D, Martella E, Lazzaretti M, Mancini C, Agnelli L, Patrene K, Maiga S, Franceschi V, Colla S, Anderson J, Neri A, Amiot M, Aversa F, David Roodman G, Giulianai N. Hypoxia-inducible factor (HIF)-1[alpha] suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction. Leukemia. 2013;27(8):1697–706.